SKYE logo

SKYE

Skye Bioscience, Inc.NASDAQHealthcare
$0.71+2.35%ClosedMarket Cap: $23.8M

As of 2026-04-07

Insider Statistics (Q1 2026)

Purchases

35

Sales

17

Buy/Sell Ratio

2.06

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell200,000$5.150
Thu Apr 02Smith Karen L.directorSell75,000$0.6275,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell200,000$0.62200,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell150,000$0.62150,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell75,000$0.6175,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell17,004$0.6217,004
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell12,000$0.6212,000
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell7,100$0.627,100
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell12,000$4.250
Thu Apr 02Twitty Christopherofficer: Chief Scientific OfficerSell75,000$14.560
Mon Feb 09Schwab Andrew J.directorSell35,000$0.8235,000
Mon Feb 09Grayson Paul A.directorSell35,000$0.8235,000
Mon Feb 09Smith Karen L.directorSell35,000$0.8235,000
Mon Feb 09ARSENAULT KAITLYNofficer: Chief Financial OfficerSell125,000$0.82125,000
Mon Feb 09Twitty Christopherofficer: Chief Scientific OfficerSell150,000$0.82150,000